Discover B2B companies, suppliers, and manufacturers related to this keyword category
A Worldwide Pharmaceutical Export Management Company
Biotech Consultancy Supporting Biopharmaceutical Development Globally
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Harnessing the power of a semi-synthetic organism with an expanded genetic alphabet to develop protein therapeutics
Passion for Innovation. Compassion for Patients.
Pioneering the Development of Novel Payloads to Power the Next Generation of ADC for Cancer
Where Empathy Meets Science to Accelerate Life Sciences Research
Passion for Innovation. Compassion for Patients.
Creating class-leading ADCs with enhanced tumor specificity
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.
Your CDMO Partner for On-Time Process Development and cGMP Manufacturing.
Discovery, optimisation and in-vivo production of a new generation of ADC payloads
Every medicine has a story. We help you write yours.
RABCancer: A Predictive Platform for Antibody-Drug Conjugates. Follow us for insights into ADC trafficking & biomarkers
Conjugate Vaccine Research & Development, Carrier Proteins, CRM197
Building tomorrow's antibody-drug conjugates (ADCs)
MANAGING CYANOBACTERIA
MANAGING CYANOBACTERIA
Find your perfect ADC with GoldenSite⢠technology | worry-free conjugation process, any payload | CHO & E. coli | ADCs
We target the cells that drive fibrosis
We target the cells that drive fibrosis
Securing Life Sciences Supply Chain - Customized conjugation & formulation solutions. celares is now part of Biosynth.
We develop advanced enzymatic solutions for toxicology, food safety, and genomics, fully designed and produced in-house.